Stocks
BioXcel (BTAI) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -41 925% | -11 987% | -1 949% | -8 195% | -8 748% | |||
| Changes by years, y/y, % | +29 938pp | +10 038pp | -6 246pp | -42.0% | |||||
BioXcel. EBITDA margin, %
BioXcel. EBITDA margin, changes, pp
BioXcel (BTAI) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -1 896% | -12 408% | -27 003% | -3 154% | -4 883% | -8 748% | |
| Changes by years, y/y, % | +2 074pp | -11 999pp | -22 432pp | -1 310pp | -2 988pp | |||
| Changes by quarters, q/q, % | -52pp | -10 512pp | -14 595pp | +23 849pp | -1 729pp | |||
